Phase I Protocol for the Evaluation of the Safety and Immunogenicity of Vaccination With Synthetic HIV Envelope Peptides in Patients With Early Human Immunodeficiency Virus Infection - Related Studies

Phase I Protocol for the Evaluation of the Safety and Immunogenicity of Vaccination With Synthetic HIV Envelope Peptides in Patients With Early Human Immunodeficiency Virus Infection

This study has been completed.

Study NCT00001386. Last updated on March 3, 2008. Information provided by National Institutes of Health Clinical Center (CC)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Acquired Immunodeficiency Syndrome
		HIV Infection

2	Additional conditions recognized in this trial
		Communicable Diseases
		HIV Infections
		Immunologic Deficiency Syndromes
		Infection
		Syndrome
		Virus Diseases

3	More general conditions related to this trial
		Disease
		Immune System Diseases
		Lentivirus Infections
		Pathologic Processes
		Retroviridae Infections
		RNA Virus Infections
		Sexually Transmitted Diseases
		Sexually Transmitted Diseases, Viral
		Slow Virus Diseases

4	Interventions listed in this trial
		PCLUS 3-18 MN
		PCLUS 6.1 MN

5	Sponsors listed in this trial
		National Cancer Institute (NCI)